Skip to main content

Find Clinical Trials

Home
Conditions
Fatty Liver Disease, Nonalcoholic

Clinical trial condition

Fatty Liver Disease, Nonalcoholic

Explore clinical trials studying Fatty Liver Disease, Nonalcoholic. Study availability and eligibility vary by location and protocol.

6 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Fatty Liver Disease, Nonalcoholic trial results

Recruiting

Digoxin In NASH (CODIN)

NCT06588699

Conditions: Digestive System Diseases, Fatty Liver, Fatty Liver Disease, +13 more
Locations: Yale New Haven Health New Haven, Connecticut, United States

Yale New Haven Hospital New Haven, Connecticut, United States

View Trial Details

Recruiting

Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial

NCT07193927

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +11 more
Locations: Hospital Universitari Dr. Josep Trueta Girona, Spain

View Trial Details

Recruiting

Thermoacoustic Method for Estimating Liver Fat Fraction

NCT07321925

Conditions: Digestive System Diseases, Fatty Liver, Fatty Liver Disease, Nonalcoholic, +3 more
Locations: ENDRA Life Sciences Ann Arbor, Michigan, United States

View Trial Details

Not Yet Recruiting

Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF

NCT06097338

Conditions: Digestive System Diseases, Fatty Liver, Fatty Liver Disease, Nonalcoholic, +2 more
Locations: Not specified

View Trial Details

Completed

Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)

NCT00596934

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +14 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy

NCT01679197

Conditions: Diabetes Mellitus, Digestive System Diseases, Dyslipidemias, +16 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details